Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

394
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
394
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.3K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.3K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

225
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
225
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

576
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
576

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Relationship Between MOTS-c K14Q Polymorphism and Sarcopenia, Blood Lipids, and Mental Health in Older Korean Adults.

Biomedicines·2024
Same author

Inferring Drug Set and Identifying the Mechanism of Drugs for PC3.

International journal of molecular sciences·2024
Same author

Cognitive Function, and Its Relationships with Comorbidities, Physical Activity, and Muscular Strength in Korean Older Adults.

Behavioral sciences (Basel, Switzerland)·2023
Same author

Association between Cardiorespiratory Fitness and Metabolic Syndrome in Korean Older Adults.

International journal of environmental research and public health·2022
Same author

Impact of Behavioral Risk Factors on Mortality Risk in Older Korean Women.

Iranian journal of public health·2022
Same author

The relationship between lifestyle risk factors and depression in Korean older adults: a moderating effect of gender.

BMC geriatrics·2022
Same journal

Widening Health Inequality and Causal Metabolic Drivers in Global Colorectal Cancer: A Multi-Dimensional Study.

Cancer informatics·2026
Same journal

GFAP-Dependent Transcriptional Dynamics and Cellular Heterogeneity in Primary, Recurrent, and Grade III Gliomas.

Cancer informatics·2026
Same journal

Translating Data Into Clinical Tools: An Integrative Strategy for Precision Biomarker Identification in Soft Tissue Sarcoma Diagnosis and Prognosis.

Cancer informatics·2026
Same journal

The MAPK Pathway Coordinates an Immunosuppressive Microenvironment in Colorectal Cancer: A Single-Cell Guided Prognostic Model.

Cancer informatics·2026
Same journal

Multi-Scale Cross-Attention Multiple Instance Learning Network for Automated Classification of Colorectal Polyps.

Cancer informatics·2026
Same journal

LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies.

Cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

1.3K

Pathway Interactions Based on Drug-Induced Datasets.

Shinuk Kim1

  • 1Department of Civil Engineering, Sangmyung University, Cheonan, Republic of Korea.

Cancer Informatics
|June 18, 2019
PubMed
Summary
This summary is machine-generated.

This study maps drug-induced pathway interactions in breast cancer cells, revealing complex networks influenced by drug combinations and identifying key signaling pathways affected by specific compounds.

Keywords:
cancerdrug-induced pathwaygene set analysisinterdrug and intradrug pathway interactions

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.6K
Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

680

Related Experiment Videos

Last Updated: Jan 23, 2026

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

1.3K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.6K
Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

680

Area of Science:

  • * Molecular Biology
  • * Bioinformatics
  • * Cancer Research

Background:

  • * MCF7 breast cancer cells are a widely used model for studying drug responses.
  • * Understanding drug-induced pathway alterations is crucial for developing effective cancer therapies.
  • * Gene set enrichment analysis provides a framework for interpreting complex biological data.

Purpose of the Study:

  • * To identify and characterize enrichment pathway connections in MCF7 cells treated with 87 drugs.
  • * To investigate intradrug and interdrug pathway interactions.
  • * To explore the potential influence of drug combinations on cellular pathways.

Main Methods:

  • * Utilized gene set enrichment analysis (GSEA) on drug-treated MCF7 cell samples (n>=5).
  • * Extracted and analyzed pathway interactions, including intradrug and interdrug effects.
  • * Quantified pathway interactions and identified key affected pathways and drug pairs.

Main Results:

  • * Identified significant pathway interactions for drugs including wortmannin, valproic acid, trichostatin A, LY294002, and sirolimus.
  • * Discovered numerous intradrug pathway interactions mediated by common genes for each drug.
  • * Observed a range of interdrug pathway interactions, with ERBB_SIGNALING and INSULIN_SIGNALING pathways showing high scores and 17-allylamino-geldanamycin with LY294002 exhibiting the most interactions.

Conclusions:

  • * Drug treatments induce complex networks of pathway interactions within breast cancer cells.
  • * Intradrug and interdrug pathway interactions provide insights into drug mechanisms and potential synergistic effects.
  • * The findings highlight the importance of considering pathway crosstalk in drug development and combination therapies.